openPR Logo
Press release

Biosimilar Market To Witness An Outstanding Growth During 2021-2027 - Dr. Reddy’s Laboratories Ltd., Sandoz International GmbH and more.

02-19-2021 07:15 AM CET | Health & Medicine

Press release from: StraitsResearch

Biosimilar Market

Biosimilar Market

Biosimilar Market Overview:

The market research report on the Global Biosimilar Market offered by Straits Research, analyses the major opportunities, CAGR, yearly growth rates to help the readers to understand the qualitative and quantitative aspects of the Global Biosimilar Market. The competition landscape, company overview, financials, recent developments and long-term investments related to the Global Biosimilar Market are mentioned in this report. Various parameters have been studied while estimating the market size. The revenue generated by the leading industry participants in the sales of the Biosimilar has been calculated through primary and secondary research. The Global Biosimilar Market analysis has been provided for the international and domestic markets, including trends, landscape analysis and key regions of development.

The global biosimilar market was valued at USD 4.49 billion in 2017 and is anticipated to reach USD 22.43 billion by 2023 at a CAGR of 30.9%.

Get Sample Copy of Biosimilar Market Research Report:
https://straitsresearch.com/report/biosimilar-market/request-sample

Leading market players Insights: The market is integrated with the presence of Biocon, Pfizer, Inc., Intas Pharmaceuticals Ltd., Dr. Reddy’s Laboratories Ltd., Sandoz International GmbH (A Novartis Division), Celltrion Inc., Teva Pharmaceutical Industries Ltd., STADA Arzneimittel AG, Amgen, Inc., and Apotex Inc. (Apobiologix)

The report is segmented in the following categories: 

By Product:
Recombinant Non-Glycosylated Proteins , Recombinant Glycosylated Proteins , Recombinant Peptides.

By Disease:
Oncology , Autoimmune Diseases , Chronic Diseases , Blood Disorders , Growth Hormone Deficiency , Infectious Diseases , Other Diseases.

Following regions are highlighted in this report: 

North America (The US, Canada, and Mexico)
Europe (Germany, France, the UK, and Rest of the World)
Asia Pacific (China, Japan, India, and Rest of Asia Pacific)
Latin America (Brazil and Rest of Latin America.)
Middle East & Africa (Saudi Arabia, the UAE, , South Africa, and Rest of Middle East & Africa) 

Key point summary of the Global Biosimilar Market report: 

This report gives out a comprehensive prospect of several factors driving or restraining market growth.
It presents an in-depth analysis of fluctuating competition dynamics and puts the reader ahead of competitors.
It provides a six-year forecast evaluated on the basis of how the market is predicted to grow.
It helps in making well-informed business decisions by creating a precise analysis of market segments and by having complete insights of the Global Biosimilar market.
This report helps users in comprehending the key product segments and their future developments. 

Reasons to Purchase this report: 

To calculate and provide the latest forecast of the Global Biosimilar Market in terms of value, by product, by applications, types and industry.
To strategically evaluate and profile key market players and comprehensively study their market position in terms of ranking and competition, and details related to the competitive landscape for the market leaders.
To calculate the forecast for the market in terms of value of various segments, by regions such as North America, Europe, Asia Pacific (APAC) and Rest of the World (RoW).
To give out detailed information related to the major factors, drivers, restrainers, opportunities, and challenges influencing the Global Biosimilar Market
Comprehensive information about the market development and emerging markets. The report also analyzes the market for various developments in different geographies.
To strategically study and analyze micro markets with respect to individual growth trends, prospects and contribution to the overall Global Biosimilar Market.

For More Insights @ https://straitsresearch.com/report/biosimilar-market

Would you like to discuss Biosimilar Market challenges with the experts at Straits Research

For more details, please contact us -
Straits Research
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY 10022
Tel: +1 646 480 7505, +44 208 068 9665
Website: https://straitsresearch.com

About Us:
Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biosimilar Market To Witness An Outstanding Growth During 2021-2027 - Dr. Reddy’s Laboratories Ltd., Sandoz International GmbH and more. here

News-ID: 2245231 • Views:

More Releases from StraitsResearch

Maleic Anhydride Market 2022: Explore Top Factors that Will Boost the Global Market by 2029
Maleic Anhydride Market 2022: Explore Top Factors that Will Boost the Global Mar …
Maleic Anhydride Market The research methodology of Straits Research involves an ideal combination of primary and secondary research with the help of which the experts' inferences and calculations are derived. Our reports are revised at regular intervals to be able to give recent information to our clients and help them make efficient business decisions. The information provided in the reports is verified in terms of quality and reliability. The Major Players Covered in this
Blood Glucose Lancets Market Emerging Technological Growth, Future Growth and Business Opportunities 2029
Blood Glucose Lancets Market Emerging Technological Growth, Future Growth and Bu …
Blood Glucose Lancets Market The research methodology of Straits Research involves an ideal combination of primary and secondary research with the help of which the experts' inferences and calculations are derived. Our reports are revised at regular intervals to be able to give recent information to our clients and help them make efficient business decisions. The information provided in the reports is verified in terms of quality and reliability. The Major Players Covered in
Graphic Film Market: Business Class Seating Type To Rising at 4.6% During 2022-2029
Graphic Film Market: Business Class Seating Type To Rising at 4.6% During 2022-2 …
Graphic Film Market The research methodology of Straits Research involves an ideal combination of primary and secondary research with the help of which the experts' inferences and calculations are derived. Our reports are revised at regular intervals to be able to give recent information to our clients and help them make efficient business decisions. The information provided in the reports is verified in terms of quality and reliability. The Major Players Covered in this
Digital PCR Market to See Wonderful Rise during 2022-2029 with High CAGR Growth
Digital PCR Market to See Wonderful Rise during 2022-2029 with High CAGR Growth
Digital PCR Market The research methodology of Straits Research involves an ideal combination of primary and secondary research with the help of which the experts' inferences and calculations are derived. Our reports are revised at regular intervals to be able to give recent information to our clients and help them make efficient business decisions. The information provided in the reports is verified in terms of quality and reliability. The Major Players Covered in this

All 5 Releases


More Releases for Biosimilar

Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Biosimilar Market Treating More for Less: The Booming Infliximab Biosimilar Mark …
Infliximab Biosimilar Market worth $ XX Million by 2030 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Infliximab Biosimilar Market- by Application (Crohn's Disease, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Plaque Psoriasis and Others), End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Direct Distribution Channels), Trends, Industry Competition Analysis, Revenue and Forecast To 2030." Get
Biosimilar Monoclonal Antibodies Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Biosimilar Monoclonal Antibodies Market by Product (infliximab, trastuzumab, rituximab, adalimumab, bevacizumab, cetuximab, ranibizumab, denosumab, eculizumab, and other pipeline products), Indication (oncology, inflammatory & autoimmune disorders, chronic diseases, blood disorders, and other indications), Clinical Trial/Pipeline Analysis, Future Trends, Industry Competition Analysis, Revenue and Forecast To 2031." The Biosimilar Monoclonal Antibodies Market Size is valued at 5.02
Infliximab Biosimilar Insight, 2023 | DelveInsight
DelveInsight's, "Infliximab Biosimilar Insight, 2023" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Interested to know more about the functioning of
Infliximab Biosimilar Insight, 2022 | DelveInsight
DelveInsight's, "Infliximab Biosimilar Insight, 2022" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Interested to know more about the functioning of